BELLEVUE ASSET MANAGEMENT, LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
BELLEVUE ASSET MANAGEMENT, LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,000
-50.0%
78
-15.2%
0.00%0.0%
Q4 2021$2,0000.0%92
-7.1%
0.00%0.0%
Q3 2021$2,000
-33.3%
990.0%0.00%
-50.0%
Q2 2021$3,0000.0%99
-8.3%
0.00%0.0%
Q1 2021$3,000
-50.0%
108
-12.9%
0.00%
-50.0%
Q4 2020$6,000
+20.0%
124
-24.8%
0.00%
+33.3%
Q3 2020$5,000
+66.7%
165
+29.9%
0.00%0.0%
Q2 2020$3,000
-40.0%
1270.0%0.00%
-40.0%
Q1 2020$5,000
+150.0%
127
+69.3%
0.01%
+150.0%
Q4 2019$2,000750.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders